Study Suggests Graphene Material Could Be Developed Further Without Acute Risk to Human Health

A groundbreaking study published in Nature Nanotechnology reveals the potential of graphene oxide to be developed further without acute risk to human health. The first controlled exposure clinical trial in people showed no short-term adverse effects on lung or cardiovascular function. This paves the way for the continued exploration and development of graphene-based solutions for global challenges, prioritizing human health and safety.